Patents by Inventor Roland Jaques

Roland Jaques has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aliphatically substituted aryl-chalcoge-no-hydrocarbon derivatives
    Patent number: 4035413
    Abstract: Compounds of the formula Ir.sub.1 -- ph -- X -- alk -- R.sub.2 (I)wherein R.sub.1 is adamantyl, Ph is phenylene which is optionally substituted by amino, nitro, lower alkyl, lower alkoxy, halogen or trifluoromethyl, X is oxy or thio, alk is alkylene with 1 to 20 C atoms or alkenylene with 2 to 20 C atoms and R.sub.2 is free, esterified or amidized carboxyl, sulpho or sulphonamido and therapeutically acceptable salts thereof are useful as anti-allergic and hypolipidaemic agents.
    Type: Grant
    Filed: August 18, 1975
    Date of Patent: July 12, 1977
    Assignee: Ciba-Geigy Corporation
    Inventors: Georges Haas, Roland Jaques, Alberto Rossi, Martin Ruegg
  • Adamantyl phenoxy alkylamides
    Patent number: 4013719
    Abstract: Compounds of the formula Ir.sub.1 -- ph -- X -- alk -- R.sub.2 (I)wherein R.sub.1 is adamantyl, Ph is phenylene which is optionally substituted by, nitro, lower alkyl, lower alkoxy, halogen or trifluoromethyl, X is oxy or thio, alk is alkylene with 1 to 20 C atoms or alkenylene with 2 to 20 C atoms and R.sub.2 is free, esterified or amidised carboxyl, sulpho or sulphonamido and therapeutically acceptable salts thereof are useful as anti-allergic and hypolipidaemic agents.
    Type: Grant
    Filed: August 18, 1975
    Date of Patent: March 22, 1977
    Assignee: Ciba-Geigy Corporation
    Inventors: Georges Haas, Roland Jaques, Alberto Rossi, Martin Ruegg
  • Adamantyl-phenoxy- and phenylthio-alkyl-alkanoyl esters
    Patent number: 4000183
    Abstract: Compounds of the formula Ir.sub.1 -- ph -- X -- alk -- R.sub.2 (I)wherein R.sub.1 is adamantyl, Ph is phenylene which is optionally substituted by amino, nitro, lower alkyl, lower alkoxy, halogen or trifluoromethyl, X is oxy or thio, alk is alkylene with 1 to 20 C atoms or alkenylene with 2 to 20 C atoms and R.sub.2 is free, esterified or amidised carboxyl, sulpho or sulphonamido and therapeutically acceptable salts thereof are useful as anti-allergic and hypolipidaemic agents.
    Type: Grant
    Filed: August 18, 1975
    Date of Patent: December 28, 1976
    Assignee: Ciba-Geigy Corporation
    Inventors: Georges Haas, Roland Jaques, Alberto Rossi, Martin Ruegg
  • Adamantyl-phenylthioalkane derivatives
    Patent number: 4000144
    Abstract: Compounds of the formula Ir.sub.1 - ph - X - alk - R.sub.2 (I)wherein R.sub.1 is adamantyl, Ph is phenylene which is optionally substituted by amino, nitro, lower alkyl, lower alkoxy, halogen or trifluoromethyl, X is oxy or thio, alk is alkylene with 1 to 20 C atoms or alkenylene with 2 to 20 C atoms and R.sub.2 is free, esterified or amidised carboxyl, sulpho or sulphonamido and therapeutically acceptable salts thereof are useful as anti-allergic and hypolipidaemic agents.
    Type: Grant
    Filed: August 18, 1975
    Date of Patent: December 28, 1976
    Assignee: Ciba-Geigy Corporation
    Inventors: Georges Haas, Roland Jaques, Alberto Rossi, Martin Ruegg
  • New aliphatically substituted aryl-chalcogeno-hydrocarbon derivatives
    Patent number: 3933835
    Abstract: Compounds of the formula IR.sub.1 -- Ph -- X -- alk -- R.sub.2 (I)wherein R.sub.1 is adamantyl, Ph is phenylene which is optionally substituted by amino, nitro, lower alkyl, lower alkoxy, halogen or trifluoromethyl, X is oxy or thio, alk is alkylene with 1 to 20 C atoms or alkenylene with 2 to 20 C atoms and R.sub.2 is free, esterfied or amidised carboxyl, sulpho or sulphonamido and therapeutically acceptable salts thereof are useful as anti-allergic and hypolipidaemic agents.
    Type: Grant
    Filed: October 24, 1973
    Date of Patent: January 20, 1976
    Assignee: Ciba-Geigy Corporation
    Inventors: Georges Haas, Roland Jaques, Alberto Rossi, Martin Ruegg